Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...
ABC — Abcam Share Price
0.000.00%
Last trade - 00:00HealthcareBalancedLarge CapHigh Flyer
- £2.53bn
- £2.66bn
- £462.90m
- 83
- 11
- 79
- 59
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 36.9 | ||
| PEG Ratio (f) | 2.6 | ||
| EPS Growth (f) | 16.52% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.87 | ||
| Price to Tang. Book | 44.51 | ||
| Price to Free Cashflow | 213.55 | ||
| Price to Sales | 5.49 | ||
| EV to EBITDA | 32.87 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.05% | ||
| Return on Equity | 2.68% | ||
| Operating Margin | 5.27% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 233.2 | 259.9 | 260 | 297.7 | 462.9 | 379.17 | 427.86 | 16.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +84.8 | -15.35 | -31.45 | -46.31 | +96.46 | +8.51 | +28.66 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for ABC
While the world wrestles with the impact of Covid, inflation and geopolitical strife, investors are naturally wondering what lies in store for some of the country's largest quoted companies, such as Abcam (LON:ABC). Abcam is an import...
Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...
Almost every industry sector has been affected in some way by the Covid-19 crisis. For investors, that means there is a lot of uncertainty about which way large-cap stocks like Abcam (LON:ABC) will move over the near term. Abcam is one...
Trying to predict how the Covid-19 crisis will impact on companies and sectors is not easy. Fortunately, large companies like Abcam (LON:ABC) are well covered by professional analysts who are used to making forecasts about them. Abcam...
Profile Summary
Abcam plc is a global life sciences company. The Company is focused on identifying, developing and distributing reagents and tools which are required in the fields of life science research. The Company's product offering includes portfolio of antibodies and related protein research tools that are fundamental to its customers' research and experimental workflow. The Company's product type includes primary antibodies, secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selector, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers. The Company's products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. The Company serves scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies.
Directors
- Alan Hirzel CEO
- Michael Baldock CFO (56)
- Marc Perkins GCN
- Mark Capone NED (58)
- Sally Crawford NED (68)
- Chienling Lee NED (55)
- Mara Aspinall NID (58)
- Giles Kerr NID (61)
- Last Annual
- December 31st, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- February 12th, 1998
- Public Since
- November 3rd, 2005
- No. of Employees
- 1,750
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 228,940,916
- Address
- Discovery Drive, CAMBRIDGE, CB20AX
- Web
- http://www.abcam.com/
- Phone
- +44 1223696000
- Auditors
- PricewaterhouseCoopers LLP
Latest News for ABC
Upcoming Events for ABC
Similar to ABC
Alliance Pharma
London Stock Exchange
Animalcare
London Stock Exchange
AstraZeneca
London Stock Exchange
Benchmark Holdings
London Stock Exchange
Beximco Pharmaceuticals
London Stock Exchange
FAQ
What is the Abcam share price?
As of Today at 07:00 UTC, shares in Abcam are trading at 1,110.00p. This share price information is delayed by 15 minutes.
How has the Abcam share price performed this year?
Shares in Abcam last closed at 1,110.00p and the price had moved by -21.44% over the past 365 days. In terms of relative price strength the Abcam share price has underperformed the FTSE All Share Index by -24.14% over the past year.
What are the analyst and broker recommendations for Abcam?
The overall consensus recommendation for Abcam is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Abcam dividend yield?
Abcam does not currently pay a dividend.
Does Abcam pay a dividend?
Abcam does not currently pay a dividend.
When does Abcam next pay dividends?
Abcam does not currently pay a dividend.
How do I buy Abcam shares?
To buy shares in Abcam you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Abcam?
As of the previous close price of 1,110.00p, shares in Abcam had a market capitalisation of £2.53bn.
Where are Abcam shares listed?
Here are the trading details for Abcam:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: ABC
What kind of share is Abcam?
Based on an overall assessment of its quality, value and momentum Abcam is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Abcam share price forecast for 2022?
The analyst consensus target price for shares in Abcam is 1,491.39p. That is 34.36% above the last closing price of 1,110.00p.
Analysts covering Abcam currently have a consensus Earnings Per Share (EPS) forecast of £0.27 for the next financial year.
What is the trend in the Abcam share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abcam. Over the past six months, its share price has underperformed the FTSE All Share Index by -34.59%.
As of the last closing price of 1,110.00p, shares in Abcam were trading -23.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Abcam PE Ratio?
The Abcam PE ratio based on its reported earnings over the past 12 months is 36.9. The shares last closed at 1,110.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Abcam?
Abcam's management team is headed by:
- Alan Hirzel - CEO
- Michael Baldock - CFO
- Marc Perkins - GCN
- Mark Capone - NED
- Sally Crawford - NED
- Chienling Lee - NED
- Mara Aspinall - NID
- Giles Kerr - NID